Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2020 17:32 ET | Source: Novavax, Inc.

Novavax Appoints Biopharmaceutical Industry Veteran Gregg Alton to Board of Directors

GAITHERSBURG, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
November 03, 2020 08:00 ET | Source: Novavax, Inc.

Novavax to Host Conference Call to Discuss Third Quarter Financial and Operating Results on November 9, 2020

GAITHERSBURG, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
November 02, 2020 08:16 ET | Source: Novavax, Inc.

Novavax Announces Facility Expansion to Support Global Vaccine Development

Expands campus with two properties to support vaccine research and development, manufacturing, business operations GAITHERSBURG, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX),...
October 27, 2020 09:03 ET | Source: Novavax, Inc.

Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update

5,500 volunteers enrolled to date in pivotal Phase 3 clinical trial in the U.K. Study expanded to 15,000 participantsFull enrollment expected by end of NovemberEvent-driven interim data expected as...
October 20, 2020 08:30 ET | Source: Novavax, Inc.

Novavax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2020

GAITHERSBURG, Md., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
October 13, 2020 08:00 ET | Source: Novavax, Inc.

Novavax Appoints Leadership Team to Advance NanoFlu through Regulatory Licensure

Team will focus on global NanoFlu licensure and evaluation of post-pandemic influenza/COVID-19 combination vaccine with NVX-CoV2373 Russell (Rip) Wilson promoted to Executive Vice President and...
October 05, 2020 09:00 ET | Source: Novavax, Inc.

Novavax to Participate in Upcoming Conferences

GAITHERSBURG, Md., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Novavax Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
September 28, 2020 09:00 ET | Source: Novavax, Inc.

Novavax to Present COVID-19, Influenza and RSV Candidate Vaccine Data at World Vaccine Congress Washington 2020

GAITHERSBURG, Md., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...
September 24, 2020 16:35 ET | Source: Novavax, Inc.

Gov. Hogan, Novavax’ Erck, & BIO’s Dr. McMurry-Heath Toured Novavax Labs and Discussed Progress on COVID-19 Vaccine

GAITHERSBURG, Md., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Today, Maryland Governor Larry Hogan and Dr. Michelle McMurry-Heath, President & CEO of Biotechnology Innovation Organization (BIO), joined...
September 24, 2020 16:05 ET | Source: Novavax, Inc.

Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom

GAITHERSBURG, Md., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right